In line with this finding, MTT assays indicated that either NQO1 siRNA or NQO1 inhibitor dicoumarol (DIC, 5 μM) could also reduce the TSA cytotoxicity in colon cancer HT29 and HCT116 cells (Figure S2). Here, NQO1 is linked to colonic neoplasm.